Lifecore Biomedical, Inc. LFCR Cash Flow Statement
| Q4 '26 | Q2 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| -$14.98M-49.9% | -$9.99M-771% | -$1.15M+92.2% | -$14.77M-125% | -$6.57M+59.5% | ||
| $2.31M+16.6% | $1.98M+3.5% | $1.91M-7.8% | $2.08M+1.6% | $2.04M+2.6% | ||
| $1.7M-29.0% | $2.39M+31.8% | $1.82M-28.9% | $2.55M-24.3% | $3.37M+39.4% | ||
| $0— | —— | -$91K+98.8% | -$7.64M— | —— | ||
| -$930K+52.7% | -$1.97M+14.6% | -$2.3M+50.1% | -$4.62M-90.2% | -$2.43M-246% | ||
| $1.43M-36.7% | $2.26M— | —— | -$3.51M— | —— | ||
| -$3.65M-2.6% | -$3.56M-1.8% | -$3.5M-1,655% | $225K+118% | -$1.26M-362% | ||
| -$209K-332% | $90K+106% | -$1.61M-1,764% | $97K-89.5% | $925K+332% | ||
| $46K+118% | -$255K— | —— | -$333K— | —— | ||
| -$6.77M-248% | $4.58M+176% | $1.66M-48.6% | $3.23M-6.2% | $3.45M+157% | ||
| $4.7M+167% | $1.76M— | —— | $1.2M+120% | -$6.14M-902% | ||
| $1.12M-35.6% | $1.74M-17.2% | $2.1M-61.6% | $5.46M+124% | $2.44M-28.7% | ||
| $0— | —— | —— | $7M— | —— | ||
| -$1.12M+35.6% | -$1.74M+17.2% | -$2.1M-236% | $1.54M+163% | -$2.44M+28.7% | ||
| $36.4M+201% | $12.1M— | —— | $33.89M— | —— | ||
| $0-100% | $1.16M+609% | $163K+21.6% | $134K-65.2% | $385K-34.6% | ||
| -$256K+81.6% | -$1.39M— | $0+100% | -$6.78M-154% | $12.52M+1,045% | ||
| $3.33M+344% | -$1.36M— | —— | -$4.04M-203% | $3.94M+234% | ||
| $2.31M— | —— | —— | $2.08M— | —— | ||
| $0— | —— | —— | -$7.64M— | —— | ||
| —— | —— | $660.5K0.0% | $660.5K0.0% | $660.5K0.0% | ||
| -$3.65M-2.6% | -$3.56M-1.8% | -$3.5M-1,655% | $225K+109% | -$2.37M-769% | ||
| $206K+104% | -$4.64M-660% | $829K+83.4% | $452K-71.3% | $1.57M+2,709% | ||
| -$209K-332% | $90K+106% | -$1.61M-1,764% | $97K-89.5% | $925K+332% | ||
| $46K+118% | -$255K— | —— | -$333K— | —— | ||
| $7.08M+15.9% | $6.11M— | —— | $5.21M— | —— | ||
| -$3.16M-741% | -$375K— | —— | -$600K-150% | $1.2M+33.3% | ||
| $0— | —— | —— | $7M— | —— | ||
| -$256K— | —— | —— | -$649K— | —— | ||
| $36.4M+201% | $12.1M— | —— | $33.89M— | —— | ||
| $36.4M+201% | $12.1M— | —— | $27.89M— | —— | ||
| $3.58M+14,228% | $25K— | —— | -$4.26M+50.4% | -$8.58M-113% | ||
| $3.58M+14,228% | $25K— | —— | -$4.26M+50.4% | -$8.58M-113% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Lifecore Biomedical, Inc. generate?
- Lifecore Biomedical, Inc. (LFCR) generated $1.5M in operating cash flow over the trailing twelve months.
- What is Lifecore Biomedical, Inc.'s free cash flow?
- After $10.4M of capital expenditures, Lifecore Biomedical, Inc.'s free cash flow was -$9.2M over the trailing twelve months, up 67.2% year over year.
- Where does Lifecore Biomedical, Inc.'s cash flow data come from?
- Every line is extracted from Lifecore Biomedical, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
